Develops BTX-A51, a novel multi-kinase inhibitor targeting cancer regulators for treating blood cancers and GATA3-mutant breast cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Edgewood Oncology is a clinical-stage biotechnology company focused on developing BTX-A51, a novel small molecule, multi-kinase inhibitor that synergistically targets master regulators of cancer to activate programmed cell death. The company is advancing clinical programs for BTX-A51 in hematologic malignancies and genetically-defined solid tumors, including GATA3-mutant breast cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Edgewood Oncology Management Team
Investors
Alta Partners
Edgewood Oncology Valuations & Financials
View real-time NPM data on Edgewood Oncology stock including daily Edgewood Oncology stock price estimates, valuation history, and historical share price information. Access Edgewood Oncology financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Edgewood Oncology pricing across six independent market signals. Looking for private company due diligence data sources on Edgewood Oncology? Get in touch to learn more.
Similar Companies
like Edgewood Oncology
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Gotham Greens
Climate & Sustainability
Produces fresh leafy greens and herbs in sustainable hydroponic greenhouses, delivering pesticide-free produce to regional markets.
Acko
Utilizes automated underwriting to offer paperless coverage policies and instant claims processing directly to consumers.
DuploCloud
Enterprise Software
Provisions infrastructure, enforces security and compliance, and streamlines operations via AI-driven workflows.
MessageGears
Provides a customer engagement platform that connects directly to cloud data warehouses to deliver secure, real-time enterprise marketing campaigns.
L3 Harris Airline Academy
Industrials
Professional flight academy delivers comprehensive commercial pilot training using modern aircraft and simulators, with airline placement support.
Quipli
Cloud-based platform streamlining equipment rental operations with unified inventory, dispatch, maintenance, payments, and customer tools.
OneEnergy Renewables
Climate & Sustainability
Delivers energy solutions that place distributed renewable generation on underutilized land to power nearby operations with clean, efficient electricity.
EdiGene
A biotechnology firm that leverages advanced gene-editing platforms to create innovative treatments for genetic disorders and oncology.
FAQ
We have answers
Edgewood Oncology stock does not trade on public stock exchanges. Edgewood Oncology stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Edgewood Oncology stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Edgewood Oncology Stock does not trade on public stock exchanges. In order to sell Edgewood Oncology shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Edgewood Oncology does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Edgewood Oncology share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Edgewood Oncology stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Edgewood Oncology stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Edgewood Oncology stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Edgewood Oncology is a private company and has not had an IPO. There is currently no Edgewood Oncology IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Edgewood Oncology IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
